Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2003New England Journal of Medicine

α4Integrins as Therapeutic Targets in Autoimmune Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

Ulrich H. von Andrian
Ulrich H. von AndrianBoston UniversityBEBritta EngelhardtUniversity of Bern

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Andrian et al. (2003) studied this question.

synapsesocial.com/papers/6a7cc99af40403d04c3f760ehttps://doi.org/10.1056/nejme020157
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A novel β 1 ‐dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration1995 · 179 citations
  2. 2Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells1997 · 365 citations
  3. 3Overlapping Roles of P-Selectin and α4 Integrin to Recruit Leukocytes to the Central Nervous System in Experimental Autoimmune Encephalomyelitis2002 · 211 citations
  4. 4Natalizumab for Active Crohn's Disease2003 · 812 citations